The Director of Biological Research & Development at Vetanco USA was part of the Western Poultry Disease Conference, organized by the American College of Poultry Veterinarians (ACPV).
The 71st Western Poultry Disease Conference was held on April 3-6 under the theme “Poultry Diseases of Concern in Modern Production Systems“, and it was organized by the American College of Poultry Veterinarians (ACPV) in Vancouver B.C., Canada. While there, Jeffrey W. Hall, Ph.D., Director of Biological Research & Development at Vetanco USA, presented initial test data of the new experimental E. coli vaccine based on the Biotech Vac vaccine platform.
“Vetanco continues to work both in the United States and Argentina on the development of new vaccines, both for our own teams and the market,” stated one of the company’s representatives.
Thus, among other innovations, the international veterinary laboratory that develops, produces, and markets innovative products for animal health and production is hoping to incorporate Biotech Vac Coli into its portfolio in the future.
